三维荧光光谱二阶校正方法测定血浆样中喷昔洛韦及泛昔洛韦含量

利用三维荧光光谱即激发发射矩阵荧光光谱与化学计量学的基于平行因子分析(PARAFAC)算法的二阶校正方法相结合,尝试对血浆样中泛昔洛韦及其活性代谢物喷昔洛韦的含量进行同时定量测定.当算法选取组分数为3时,解析得到血浆样中泛昔洛韦和喷昔洛韦的平均回收率分别为(102.4±3.4)%和(105.1±2.3)%.结果表明该分析策略可准确可靠地实现血浆样中泛昔洛韦和喷昔洛韦的直接同时快速定量测定.     

三维荧光二阶校正法用于血浆和尿液中柔红霉素的快速测定

文章采用三维激发发射荧光光谱与化学计量学交替三线性分解(ATLD)二阶校正法相结合,对血浆液和尿液中柔红霉素(DM)进行定量测定。实验不需对血浆和尿液预测样进行萃取等分离预处理,选取激发波长410～530nm,发射波长550～650nm,分别每隔5nm取一个数据,利用激发发射荧光扫描分别获得两个三维响应数阵(大小为21×25×12)。当组分数选择为3时,血浆和尿液校正集中盐酸柔红霉素的相对浓度与实际浓度的相关系数分别为r1=0.9990和r2=0.9952,经ATLD算法解析得到的血浆和尿液预测样中柔红霉素平均回收率分别为(92.8±7.6)%和(94.7±4.4)%。实验结果表明,此法能够解决血浆和尿液中盐酸柔红霉素药物因血浆和尿液内源物质与分析物光谱重叠所引起的难分辨的问题,可用于未知干扰共存下柔红霉素的直接快速定量测定。     

三维荧光二阶校正方法快速检测香蕉中双苯三唑醇含量

利用交替三线性分解(ATLD)、交替拟合残差(AFR)和自加权交替三线性分解(SWATLD)等3种二阶校正算法分别对三维荧光光谱数据进行解析,实现了香蕉中的双苯三唑醇含量的直接快速定量测定.当被分析体系的组分数取2时, ATLD、AFR和SWATLD获得的平均回收率分别为(98.2±2.6)%、(97.6±2.1)%和(91.5±3.5)%.另外,采用椭圆置信区间测试(EJCR)和品质因子,如灵敏度(SEN)、选择性(SEL)和检出限(LOD)评估了3种算法的准确性.实验结果表明:3种算法均能成功用于直接分析香蕉中双苯三唑醇的含量.     

三维荧光结合交替三线性分解方法测定中药鬼臼和人体体液中鬼臼毒素含量

本文采用三维荧光光谱结合化学计量学交替三线性分解(ATLD)方法,对中药鬼臼和人体体液中鬼臼毒素的含量和回收率进行测定,利用核一致诊断法对体系的组分数进行了估计。采用标准曲线法和二阶标准加入法得到的鬼臼中鬼臼毒素的含量分别为4.855%±0.14%和4.558%±0.05%,回收率为101.4%±1.2%,人体血浆和尿液中鬼臼毒素的回收率分别为101.4%±3.9%和99.4%±0.9%,得到的鬼臼毒素的解析光谱与真实光谱几乎完全重合。实验结果表明,该方法可用于干扰组分共存下中药鬼臼和人体体液中鬼臼毒素的快速、准确定量分析。同时,讨论了内滤光效应对定量测定鬼臼毒素的影响及其校正方法,吸光度校正后的定量测定结果更好。     

三维荧光结合二阶校正法测定蛇床子及人体血浆中蛇床子素的含量

利用二阶校正的平行因子分析(PARAFAC)算法,交替三线性(ATLD)算法和自加权交替三线性(SWATLD)算法辅助三维荧光对中药蛇床子和人体血浆中蛇床子素进行了定性及定量分析。中药蛇床子和人体血浆体系中背景复杂,与蛇床子素的荧光峰有严重的重叠。然而,PARAFAC算法,ATLD算法和SWATLD算法具有独特的"二阶优势",即使在有未知干扰存在的情况下也能得到令人满意的结果。三种方法测得的蛇床子素在中药蛇床子中的回收率分别为103.6%,101.5%和103.0%,在血浆中的回收率分别为111.1%,100.0%和106.6%,得到的蛇床子素解析光谱和真实光谱几乎完全重合。实验结果说明,这三种化学计量学二阶校正算法可以在有未知干扰组分共存的情况下对蛇床子素进行准确而有效的定性及定量测定。     

三维荧光光谱结合二阶校正算法测定人体血浆和厚朴药材中的厚朴酚及和厚朴酚

利用三维荧光光谱与化学计量学二阶校正算法相结合, 直接测定人体血浆中和厚朴药材中的厚朴酚及和厚朴酚. 采用平行因子分析(PARAFAC)算法解析所得两种物质的回收率分别为(99.5±2.6)%和(90.2±1.8)%. 采用交替三线性分解(ATLD)算法解析, 当组分数N取3时, 回收率分别为(104.2±3.2)%和(98.7±4.0)%; 当N取4时, 回收率分别为(102.7±2.9)%和(99.0±4.6)%. 同时用该方法对厚朴药材中的厚朴酚及和厚朴酚进行快速定量测定, 结果令人满意. 实验结果表明, 此法可用于复杂试样中未知干扰共存下厚朴酚及和厚朴酚的同时测定.     

三维荧光二阶校正法同时测定水果样中α-萘乙酸和吲哚-3-乙酸

将三维荧光光谱技术与分别基于交替惩罚三线性分解(APTLD)和平行因子分析(PARAFAC)2种算法的二阶校正方法相结合,实现了水果样中α-萘乙酸(NAA)和吲哚-3-乙酸(IAA)含量的直接快速同时定量测定.对于西瓜提取液,在量测体系选取的组分数为3时,采用APTLD二阶校正法所获得的NAA和IAA的平均回收率分别为...     

三维荧光光谱结合交替三线性分解二阶校正法同时测定血浆样中三种抗癌药物含量

姜黄素、阿霉素和白藜芦醇对多种恶性肿瘤的治愈皆有一定的疗效,且其联合用药对癌细胞的抑制效果更加显著．本文采用三维激发发射荧光光谱结合基于交替三线性分解（Alternating Trilinear Decomposition,ATLD）算法的化学计量学二阶校正法,同时对血浆样中姜黄素、盐酸阿霉素和白藜芦醇的含量进行了定量分析研究．当量测体系的组分数预估计取4时,ATLD方法解析得到的血浆样中姜黄素、盐酸阿霉素和白藜芦醇的平均回收率分别为（91．4±1．1）％、（104．5±2．8）％和（103．4±4．7）％．实验结果表明,此法能够解决干扰共存和荧光光谱重叠下血浆样中姜黄素、盐酸阿霉素和白藜芦醇的直接、快速、同时定量分析的难题．     

三维荧光光谱结合二阶校正方法测定细胞培养基中阿霉素的含量

本文采用交替三线性分解(ATLD)和交替归一加权残差三线性分解(ANWE)两种二阶校正方法结合激发发射矩阵荧光光谱对完全不经任何预处理的细胞培养基中的阿霉素进行简单、快速、直接的定量测定.当算法选取组分数为2时,解析得到细胞培养基中阿霉素的平均回收率分别为(100.5±1.8)%和(100.3±1.9)%.在细胞培养基中加入烟酰胺腺嘌呤二核苷酸(NADH)、烟酰胺腺嘌呤二核苷酸磷酸(NADPH)、黄素腺嘌呤二核苷酸(FAD)和黄素单核苷酸(FMN)四种细胞内的自发荧光物后,选取组分数为4时,解析得到细胞培养基中阿霉素的平均回收率分别为(99.1±2.9)%和(99.2±3.1)%.结果表明该分析方法能够准确、快速地直接测定细胞培养基中阿霉素的含量,并且在模拟细胞内荧光干扰环境下可定量测定阿霉素,且能获得令人满意的结果.     

三维荧光光谱结合二阶校正算法用于尿液中常见毒品的检测

利用三维荧光光谱技术结合二阶校正算法对尿液中冰毒、3,4-亚甲基二氧基甲基苯丙胺、可卡因和吗啡4种毒品进行快速定量分析.结果表明,平行因子(PARAFAC)、交替三线性分解(ATLD)和自加权交替三线性分解(SWATLD)算法均能很好地分辨出待测组分,且通过PARAFAC与SWATLD算法解析三维光谱数据获得的尿液背景干扰下4种毒品的平均回收率为92.8%~106.1%,相对误差低于8%.三维荧光光谱结合二阶校正算法可用于常见毒品滥用者的快速检测,为缉毒禁毒工作提供新的检测手段.     

Simultaneous determination of benserazide and levodopa by capillary electrophoresis-chemiluminescence using an improved interface

A capillary electrophoresis coupling with indirect chemiluminescence detection method for the simultaneous determination of benserazide and levodopa has been developed. The detection interface was improved to simplify the capillary electrophoresis-chemiluminescence (CE-CL) system and the features of this improved interface were illustrated in this paper. The CE-CL conditions for the simultaneous determination of benserazide and levodopa were optimized. Under the optimal conditions, the CL intensity was linear with concentrations of levodopa in the range of 1.0 to 100.0 microg ml(-1), and benserazide in the range of 10.0 to 1,000 microg ml(-1), respectively. The detection limits (S/N=3) in turn were 1.85 microg ml(-1) for BS and 0.12 microg ml(-1) for L-dopa with relative standard deviations of less than 3%. The proposed method has been successfully applied to the determination of benserazide and levodopa in medopar tablets and spiked urine samples, demonstrating the feasibility and reliability of the proposed method.     

Application of silver nanoparticles and principal component-artificial neural network models for simultaneous determination of levodopa and benserazide hydrochloride by a kinetic spectrophotometric method

A multicomponent analysis method based on principal component analysis-artificial neural network model (PC-ANN) is proposed for the simultaneous determination of levodopa (LD) and benserazide hydrochloride (BH). The method is based on the reaction of levodopa and benserazide hydrochloride with silver nitrate as an oxidizing agent in the presence of PVP and formation of silver nanoparticles. The reaction monitored at analytical wavelength 440 nm related to surface plasmon resonance band of silver nanoparticles. Differences in the kinetic behavior of the levodopa and benserazide hydrochloride were exploited by using principal component analysis, an artificial neural network (PC-ANN) to resolve concentration of analytes in their mixture. After reducing the number of kinetic data using principal component analysis, an artificial neural network consisting of three layers of nodes was trained by applying a back-propagation learning rule. The optimized ANN allows the simultaneous determination of analytes in mixtures with relative standard errors of prediction in the region of 4.5 and 6.3 for levodopa and benserazide hydrochloride respectively. The results show that this method is an efficient method for prediction of these analytes.     

Capillary electrophoresis-chemiluminecence detection of levodopa and benserazide in Medopar tablet

A novel method for the simultaneous determination of benserazide and levodopa using capillary electrophoresis(CE)- chemiluminescence(CL)has been developed.Under the optimal conditions,the detection limits(S/N=3)were 1.85μg/mL for benserazide and 0.12μg/mL for levodopa.This method was successfully applied to the determination of benserazide and levodopa in Medopar tablet,the results showed that the detected values are in accordance with those by official methods.     

Development and validation of an LC‐MS/MS method for simultaneous quantification of levodopa and MD01 in rat plasma and its application to a pharmacokinetic study of mucuna pruriens extract

Mucuna pruriens, an ancient Indian herbal medicine containing levodopa, is widely used for Parkinson's disease. In order to simultaneously determine levodopa and 1,1‐dimethyl‐3‐carboxy‐6,7‐dihydroxy‐1,2,3,4‐tetrahydroisoquinoline (MD01) in rat plasma, an improved LC‐MS/MS method was developed and validated for a pharmacokinetic study in rats orally administered levodopa or Mucuna pruriens extract (MPE). Elimination of matrix effect and improvement of extraction recovery were achieved through systematic optimization of reversed‐phase and hydrophilic interaction chromatographic conditions together with sample clean‐up procedures. A satisfactory chromatographic performance was obtained with a Thermo Aquasil C₁₈ column (50 × 2.1 mm, 3 µm) using acetonitrile and water containing 0.2% formic acid as mobile phases. Futhermore, sodium metabisulfite and formic acid were used as stabilizers in neat solutions as well as rat plasma. The method was validated in a dynamic range of 20.0–10,000 ng/mL for levodopa and MD01; the intra‐ and inter‐day precision and accuracy were acceptable. The method was successfully utilized to determine the levodopa level in plasma samples of rats administered levodopa or MPE. Pharmacokinetic results showed that an increase in the AUC of levodopa was observed in rats following oral administration of multiple doses of MPE. Copyright © 2016 John Wiley & Sons, Ltd.     

Simultaneous Determination of Levodopa and Its Metabolite in Human Blood by Capillary Electrophoresis with Laser‐induced Fluorescence Detection

A rapid, sensitive and reproducible method is described for the analysis of levodopa and its metabolite dopamine (DA) in human blood. The influence of carbidopa as the inhibitor againist the decarboxylase activity on the metabolism has been also studied. After derivatization in a dark pulsator for 12 h at room temperature, the fluorescein isothiocyanate (FITC) derivative of levodopa and other components were separated by capillary zone electrophoresis (CZE) within 13 min and detected with laser-induced fluorescence (LIF). Under the optimum analysis conditions, the linear range is 3.0×10^－8—4.0×10^－6 mol/L and 1.0×10^－8—2.0×10^－6 mol/L for levodopa and DA, respectively. The detection limits of levodopa and DA were 7.8×10^－9 mol/L (39.0 amol) and 3.1×10^－9 mol/L (15.5 amol), respectively. The method was successfully applied to monitoring the levodopa and DA in human blood after one took tablets orally.     

Simultaneous Chemiluminometric Determination of Levodopa and Benserazide in a Multi-pumping Flow System with Multivariate Calibration

An automated multi-pumping flow system is proposed for the simultaneous chemiluminometric determination of benserazide and levodopa using multivariate calibration methods. The developed methodology is based on chemiluminescence (CL) emission generated by the reaction of benserazide with luminol, and on a concurrent inhibiting effect of levodopa on this reaction. A multi-pumping flow system comprising multiple solenoid micro-pumps as the only active components was developed to implement a stopped-flow approach for signal acquisition and processing. Artificial neural networks were used to establish a relationship between the CL emission profile and the concentration of both drugs. The concentration values used to establish the experimental calibration samples were varied between 5 and 30 mg l(-1) for levodopa and between 2.5 and 20 mg l(-1) for benserazide. The proposed method was successfully applied to the simultaneous determination of levodopa and benserazide in pharmaceutical formulations combining both drugs.     

LC–ESI/MS Analysis of Levodopa and Methyldopa (IS) in Beagle Dog Pharmacokinetic Study after Oral Administration and Domperidone Given in Advance

A simple, sensitive and accurate method was developed for the quantification of levodopa and methyldopa (IS) in beagle dog plasma by LC–ESI/MS, chromatographic separation was carried out by a Diamonsil C18 column (150 mm × 4.6 mm i.d., 5 mm) with an ODS guard column maintained at 30 °C. The mobile phase was methanol (A) and 0.5% formic acid aqueous solution (B) system in the gradient elution profile, the retention time of levodopa and IS were 4.8 and 6.1 min, respectively, linear range for levodopa concentration was 0.08‐20.0 μg/mL in plasma samples with a correlation coefficient(r) of 0.9978, the limit of detection was 32 ng/mL. CV of intra‐day and inter‐day assays were all less than 15%, mean recoveries of levodopa were all more than 90% in 0.32, 1.6 and 16.0 μg/mL concentrations of levodopa (n = 3). The validated method was successfully applied to the determination of levodopa in plasma samples, pharmacokinetic of levodopa following a single oral dose of compound levodopa tablets and antiemetic drug – domperidone administrated to beagle dogs has been carried out, the main pharmacokinetic parameters of levodopa with domperidone were as follows: T_max (0.50 ± 0.18) h, C_max (39.72 ± 7.91) μg/mL, t_l/2 (0.65 ± 0.07) h, AUC_o‐t (49.01 ± 12.13) μg·h/mL , AUC_o‐∞ (49.10 ± 12.16) μg·h/mL, we also evaluated the effect of domperidone on pharmacokinetics of levodopa in beagle dog. We thought non‐oral sustained‐release formulations should be a very good choice instead of this common oral dosage forms on the market, the test results can provide a reference for clinical trials on drug therapy of Parkinson‘s disease.     

Determination of levodopa in pharmaceutical preparations by irreversible biamperometry

Based on the electrocatalytic oxidation of levodopa at gold electrode and the reduction of permanganate at platinum electrode, a novel flow injection irreversible biamperometric method is developed for the determination of levodopa under the potential difference of 0 V imposed between two electrodes. In H2SO4 solution, the linear relationships between currents and the concentrations of levodopa are obtained in the range from 0.04 mg/L to 20 mg/L with the detection limit of 0.012 mg/L. The proposed method is applied to the determination of levodopa in pharmaceutical preparations.     

毛细管电泳法同时测定血清中的左旋多巴和甲基多巴

建立了毛细管电泳-紫外检测同时测定血清中左旋多巴和甲基多巴的方法。以40 mmol/L硼砂（pH 9.5）为分离缓 冲溶液,在3.45 kPa（0.5 psi）压力下进样7 s、分离电压22 kV、检测波长200 nm、温度25 ℃的条件下进行测定,两 种物质获得了较好的分离。甲基多巴和左旋多巴分别为1.0~64.0 mg/L和1.0~71.0 mg/L时与峰面积呈良好的线性关系, 线性相关系数分别为0.9998和0.9994,检出限分别为0.6和0.8 mg/L(以信噪比为3计)。将该法用于血清中甲基多巴和左 旋多巴的测定,回收率为82.8%~88.8%,相对标准偏差为2.10%~2.63%。     

Exfoliated graphite nanoplatelets and gold nanoparticles based electrochemical sensor for determination of levodopa

This paper describes a rapid, accurate, and sensitive method for the determination of levodopa in a pharmaceutical sample using a glassy carbon electrode modified with a hybrid nanocomposite constituted of exfoliated graphite nanoplatelets dispersed in a suspension of gold nanoparticles in carboxymethylcelullose (AuNP-CMC-xGnP/GCE). The nanocomposite was characterized by scanning electron microscopy, transmission electron microscopy, UV-Vis spectroscopy, and zeta potential. Electrochemical characterization of the proposed sensor by cyclic voltammetry and electrochemical impedance spectroscopy indicated that the nanocomposite used for the electrode modification facilitated electron transfer. Using square-wave voltammetry (SWV) under optimized conditions (0.50% (m/v) of AuNP-CMC-xGnP, 0.1 mol L^?1 sulfuric acid, frequency 30 Hz, pulse amplitude 50 mV, and scan increment 6.0 mV), the calibration curve showed a linear range for levodopa from 5 to 50 μmol L^?1, with a limit of detection of 0.5 μmol L^?1. The sensor demonstrated good repeatability and electrode-to-electrode repeatability, with relative standard deviations of 2 and 4%, respectively. The proposed method was successfully applied to quantify levodopa in a pharmaceutical sample by SWV, showing good accuracy. Recoveries of 98 to 107% demonstrated that the method is suitable for practical applications. Therefore, the proposed sensor represents a useful tool for rapid and accurate determination of levodopa.